Symbols / PGEN $3.54 +0.85%
PGEN Chart
About
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients. It also develops programs based on the UltraCAR-T platform, including PRGN-3005 in Phase 1b clinical trial to treat advanced ovarian, fallopian tube, or primary peritoneal cancer; PRGN-3006 in Phase 1b trial for patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes; and PRGN-3007 in Phase 1/1b trial for the treatment of advanced receptor tyrosine kinase-like orphan receptor 1-positive, hematologic, and solid tumors. In addition, the company is developing programs based on the AdenoVerse immunotherapy platform comprising PRGN-2009 in Phase 2 trial for patients with HPV+ solid tumors; PRGN-2012 in Phase ½ trial to treat recurrent respiratory papillomatosis; and AG019, which is in Phase 1b/2a trial, to treat type 1 diabetes mellitus. Further, it provides UltraPorator, a proprietary electroporation device; and develops research models and services for healthcare research applications. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in February 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 1.25B |
| Enterprise Value | 1.22B | Income | -425.87M | Sales | 6.31M |
| Book/sh | 0.12 | Cash/sh | 0.34 | Dividend Yield | — |
| Payout | 0.00% | Employees | 143 | IPO | — |
| P/E | — | Forward P/E | -16.09 | PEG | — |
| P/S | 198.53 | P/B | 30.00 | P/C | — |
| EV/EBITDA | -11.62 | EV/Sales | 193.21 | Quick Ratio | 3.81 |
| Current Ratio | 4.04 | Debt/Eq | 234.53 | LT Debt/Eq | — |
| EPS (ttm) | -1.42 | EPS next Y | -0.22 | EPS Growth | — |
| Revenue Growth | 206.60% | Earnings | 2026-03-25 | ROA | -52.83% |
| ROE | -5.08% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | -11.80% | Profit Margin | 0.00% | Shs Outstand | 353.82M |
| Shs Float | 165.17M | Short Float | 18.31% | Short Ratio | 9.74 |
| Short Interest | — | 52W High | 5.47 | 52W Low | 1.11 |
| Beta | 1.17 | Avg Volume | 4.49M | Volume | 822.65K |
| Target Price | $8.50 | Recom | None | Prev Close | $3.51 |
| Price | $3.54 | Change | 0.85% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$8.50
Mean price target
2. Current target
$3.54
Latest analyst target
3. DCF / Fair value
$-2.43
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.54
Low
$8.00
High
$9.00
Mean
$8.50
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-11-14 | main | HC Wainwright & Co. | Buy → Buy | $9 |
| 2025-08-19 | main | JMP Securities | Market Outperform → Market Outperform | $8 |
| 2025-08-19 | reit | HC Wainwright & Co. | Buy → Buy | $9 |
| 2025-08-15 | up | JP Morgan | Underweight → Neutral | — |
| 2025-08-15 | main | HC Wainwright & Co. | Buy → Buy | $9 |
| 2025-08-13 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2025-06-12 | reit | JMP Securities | Market Outperform → Market Outperform | $6 |
| 2025-05-15 | reit | Cantor Fitzgerald | Overweight → Overweight | — |
| 2025-03-20 | reit | Citizens Capital Markets | Market Outperform → Market Outperform | $6 |
| 2025-03-20 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2025-01-23 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2025-01-22 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2025-01-14 | reit | JMP Securities | Market Outperform → Market Outperform | $5 |
| 2024-11-15 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2024-08-15 | main | JMP Securities | Market Outperform → Market Outperform | $7 |
| 2024-08-15 | main | HC Wainwright & Co. | Buy → Buy | $4 |
| 2024-06-04 | reit | JMP Securities | Market Outperform → Market Outperform | $14 |
| 2024-06-03 | main | Stifel | Buy → Buy | $10 |
| 2024-06-03 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-05-15 | reit | Cantor Fitzgerald | — → Overweight | — |
- RSU vesting gives Precigen (PGEN) director 71839 new common shares - Stock Titan Mon, 16 Mar 2026 21
- Precigen (NASDAQ:PGEN) Stock Price Up 7.5% - Should You Buy? - MarketBeat Fri, 13 Mar 2026 16
- Assessing Precigen (PGEN) Valuation After Recent Share Price Weakness And Conflicting Fair Value Estimates - Yahoo Finance hu, 12 Mar 2026 21
- Is Precigen (PGEN) Reflecting Its Recent Surge Despite Steep Short Term Pullback - simplywall.st Fri, 13 Mar 2026 09
- Precigen (PGEN) director exercises RSUs, adds 71,839 common shares - Stock Titan Mon, 16 Mar 2026 21
- Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN) - MSN Sat, 14 Mar 2026 05
- $PGEN stock is down 8% today. Here's what we see in our data. - Quiver Quantitative Wed, 18 Feb 2026 08
- Precigen (PGEN) insider exercises 143,678 RSUs into common stock - Stock Titan Mon, 16 Mar 2026 21
- Precigen (PGEN) Surged Following the Early Approval of Papziemos - Yahoo Finance hu, 05 Mar 2026 08
- Precigen (NASDAQ:PGEN) Upgraded at Zacks Research - MarketBeat hu, 12 Mar 2026 11
- Why Precigen (PGEN) Is Down 11.5% After Mixed Quarterly Results And What's Next - simplywall.st Fri, 06 Mar 2026 08
- Boxer Capital Management LLC Makes New $2.80 Million Investment in Precigen, Inc. $PGEN - MarketBeat Sun, 15 Mar 2026 11
- Precigen, Inc. (NASDAQ:PGEN) is definitely on the radar of institutional investors who own 31% of the company - Yahoo Finance Sun, 14 Dec 2025 08
- Precigen (PGEN) director awarded stock, RSUs and options as board fees - Stock Titan hu, 12 Mar 2026 20
- Precigen (PGEN) to Release Quarterly Earnings on Wednesday - MarketBeat Wed, 11 Mar 2026 06
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 14245 | 50000.0 | — | Stock Award(Grant) at price 3.51 per share. | FRANK STEVEN R | Director | — | 2026-03-10 00:00:00 | D |
| 1 | 17948 | 62997.0 | — | Stock Award(Grant) at price 3.51 per share. | GUPTA VINITA D | Director | — | 2026-03-10 00:00:00 | D |
| 2 | 19658 | 69000.0 | — | Stock Award(Grant) at price 3.51 per share. | KINDLER JEFFREY B | Director | — | 2026-03-10 00:00:00 | D |
| 3 | 28490 | 100000.0 | — | Stock Award(Grant) at price 3.51 per share. | KIRK RANDAL JOE | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2026-03-10 00:00:00 | I |
| 4 | 16096 | 56497.0 | — | Stock Award(Grant) at price 3.51 per share. | AGEE NANCY HOWELL | Director | — | 2026-03-10 00:00:00 | D |
| 5 | 17806 | 62499.0 | — | Stock Award(Grant) at price 3.51 per share. | TURLEY JAMES S | Director | — | 2026-03-10 00:00:00 | D |
| 6 | 17806 | 62499.0 | — | Stock Award(Grant) at price 3.51 per share. | ALVAREZ CESAR LICINIO | Director | — | 2026-03-10 00:00:00 | D |
| 7 | 17948 | 62997.0 | — | Stock Award(Grant) at price 3.51 per share. | HASSAN FRED | Director | — | 2026-03-10 00:00:00 | D |
| 8 | 1900036 | 7942150.0 | — | Sale at price 4.18 per share. | KIRK RANDAL JOE | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-12-22 00:00:00 | I |
| 9 | 235467 | 855899.0 | — | Sale at price 3.63 per share. | KINDLER JEFFREY B | Director | — | 2025-12-12 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -564.73K | -51.50K | -2.65K | -782.94 |
| TaxRateForCalcs | 0.01 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -83.17M | -78.39M | -61.31M | -77.91M |
| TotalUnusualItems | -40.32M | -10.84M | -1.12M | -543.00K |
| TotalUnusualItemsExcludingGoodwill | -40.32M | -10.84M | -1.12M | -543.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -126.23M | -95.90M | -79.78M | -110.81M |
| ReconciledDepreciation | 4.53M | 6.67M | 10.77M | 13.76M |
| ReconciledCostOfRevenue | 4.27M | 6.12M | 6.34M | 5.75M |
| EBITDA | -123.50M | -89.23M | -62.43M | -78.45M |
| EBIT | -128.02M | -95.89M | -73.19M | -92.21M |
| NetInterestIncome | 1.41M | 2.77M | -6.64M | -18.58M |
| InterestExpense | 6.00K | 468.00K | 6.77M | 18.75M |
| InterestIncome | 1.42M | 3.24M | 133.00K | 171.00K |
| NormalizedIncome | -86.48M | -85.12M | -78.66M | -110.26M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -126.23M | -95.90M | 28.32M | -92.17M |
| TotalExpenses | 98.63M | 95.15M | 101.52M | 105.67M |
| TotalOperatingIncomeAsReported | -135.03M | -99.76M | -75.73M | -91.95M |
| DilutedAverageShares | 267.73M | 244.54M | 200.36M | 197.76M |
| BasicAverageShares | 267.73M | 244.54M | 200.36M | 197.76M |
| DilutedEPS | -0.47 | -0.39 | 0.14 | -0.47 |
| BasicEPS | -0.47 | -0.39 | 0.14 | -0.47 |
| DilutedNIAvailtoComStockholders | -126.23M | -95.90M | 28.32M | -92.17M |
| NetIncomeCommonStockholders | -126.23M | -95.90M | 28.32M | -92.17M |
| NetIncome | -126.23M | -95.90M | 28.32M | -92.17M |
| MinorityInterests | 0.00 | |||
| NetIncomeIncludingNoncontrollingInterests | -126.23M | -95.90M | 28.32M | -92.17M |
| NetIncomeDiscontinuousOperations | 0.00 | 0.00 | 108.09M | 18.64M |
| NetIncomeContinuousOperations | -126.23M | -95.90M | -79.78M | -110.81M |
| TaxProvision | -1.79M | -458.00K | -189.00K | -160.00K |
| PretaxIncome | -128.03M | -96.36M | -79.97M | -110.97M |
| OtherIncomeExpense | -34.73M | -10.21M | 1.28M | -978.00K |
| OtherNonOperatingIncomeExpenses | 5.59M | 627.00K | 1.54M | -432.00K |
| SpecialIncomeCharges | -40.32M | -10.84M | -1.12M | -543.00K |
| WriteOff | 543.00K | |||
| ImpairmentOfCapitalAssets | 40.32M | 10.84M | 1.12M | 543.00K |
| RestructuringAndMergernAcquisition | 0.00 | |||
| EarningsFromEquityInterest | 0.00 | 0.00 | 862.00K | -3.00K |
| NetNonOperatingInterestIncomeExpense | 1.41M | 2.77M | -6.64M | -18.58M |
| InterestExpenseNonOperating | 6.00K | 468.00K | 6.77M | 18.75M |
| InterestIncomeNonOperating | 1.42M | 3.24M | 133.00K | 171.00K |
| OperatingIncome | -94.70M | -88.92M | -74.61M | -91.41M |
| OperatingExpense | 94.36M | 89.03M | 95.18M | 99.93M |
| ResearchAndDevelopment | 53.07M | 48.61M | 47.17M | 47.93M |
| SellingGeneralAndAdministration | 41.29M | 40.41M | 48.01M | 51.99M |
| GrossProfit | -342.00K | 106.00K | 20.57M | 8.52M |
| CostOfRevenue | 4.27M | 6.12M | 6.34M | 5.75M |
| TotalRevenue | 3.92M | 6.22M | 26.91M | 14.27M |
| OperatingRevenue | 3.89M | 6.22M | 26.66M | 13.77M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 7.48M | |||
| OrdinarySharesNumber | 292.87M | 248.92M | 208.15M | 206.74M |
| ShareIssued | 292.87M | 256.40M | 208.15M | 206.74M |
| NetDebt | 38.36M | 143.51M | ||
| TotalDebt | 5.50M | 7.10M | 51.42M | 190.07M |
| TangibleBookValue | 14.92M | 51.19M | 44.88M | 17.50M |
| InvestedCapital | 38.51M | 118.50M | 169.48M | 287.28M |
| WorkingCapital | 80.90M | 45.77M | 39.51M | 121.98M |
| NetTangibleAssets | 14.92M | 51.19M | 44.88M | 17.50M |
| CapitalLeaseObligations | 5.50M | 7.10M | 8.20M | 10.14M |
| CommonStockEquity | 38.51M | 118.50M | 126.26M | 107.35M |
| TotalCapitalization | 38.51M | 118.50M | 126.26M | 287.23M |
| TotalEquityGrossMinorityInterest | 38.51M | 118.50M | 126.26M | 107.35M |
| StockholdersEquity | 38.51M | 118.50M | 126.26M | 107.35M |
| GainsLossesNotAffectingRetainedEarnings | 12.00K | -1.95M | -3.49M | 203.00K |
| OtherEquityAdjustments | 12.00K | -1.95M | -3.49M | 203.00K |
| RetainedEarnings | -2.09B | -1.96B | -1.87B | -1.92B |
| AdditionalPaidInCapital | 2.13B | 2.08B | 2.00B | 2.02B |
| CapitalStock | 0.00 | 0.00 | 0.00 | 0.00 |
| CommonStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 106.75M | 32.55M | 89.72M | 252.51M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 85.23M | 9.56M | 11.07M | 217.86M |
| OtherNonCurrentLiabilities | 50.00K | |||
| LiabilitiesHeldforSaleNonCurrent | 0.00 | 3.67M | ||
| PreferredSecuritiesOutsideStockEquity | 28.22M | 0.00 | ||
| DerivativeProductLiabilities | 50.54M | 0.00 | ||
| NonCurrentDeferredLiabilities | 1.93M | 3.67M | 4.08M | 25.56M |
| NonCurrentDeferredRevenue | 1.93M | 1.82M | 1.82M | 23.02M |
| NonCurrentDeferredTaxesLiabilities | 0.00 | 1.85M | 2.26M | 2.54M |
| LongTermDebtAndCapitalLeaseObligation | 4.55M | 5.89M | 6.99M | 188.63M |
| LongTermCapitalLeaseObligation | 4.55M | 5.89M | 6.99M | 8.75M |
| LongTermDebt | 179.88M | |||
| CurrentLiabilities | 21.52M | 22.98M | 78.64M | 34.65M |
| OtherCurrentLiabilities | 12.85M | |||
| CurrentDeferredLiabilities | 589.00K | 509.00K | 25.00K | 1.49M |
| CurrentDeferredRevenue | 589.00K | 509.00K | 25.00K | 1.49M |
| CurrentDebtAndCapitalLeaseObligation | 956.00K | 1.20M | 44.43M | 1.45M |
| CurrentCapitalLeaseObligation | 956.00K | 1.20M | 1.21M | 1.39M |
| CurrentDebt | 43.22M | 52.00K | ||
| OtherCurrentBorrowings | 43.22M | 52.00K | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 8.42M | 8.25M | 6.38M | 7.86M |
| PayablesAndAccruedExpenses | 11.56M | 13.02M | 27.82M | 11.00M |
| CurrentAccruedExpenses | 8.03M | 11.30M | 23.75M | 7.82M |
| Payables | 3.53M | 1.73M | 4.07M | 3.19M |
| DuetoRelatedPartiesCurrent | 0.00 | 74.00K | ||
| AccountsPayable | 3.53M | 1.73M | 4.07M | 3.11M |
| TotalAssets | 145.27M | 151.04M | 215.98M | 359.86M |
| TotalNonCurrentAssets | 42.85M | 82.29M | 97.82M | 203.23M |
| OtherNonCurrentAssets | 459.00K | 846.00K | 1.15M | 46.27M |
| InvestmentsAndAdvances | 0.00 | 48.56M | ||
| InvestmentinFinancialAssets | 0.00 | 48.56M | ||
| AvailableForSaleSecurities | 48.56M | |||
| GoodwillAndOtherIntangibleAssets | 23.59M | 67.31M | 81.38M | 89.84M |
| OtherIntangibleAssets | 4.46M | 40.70M | 44.45M | 52.29M |
| Goodwill | 19.14M | 26.61M | 36.92M | 37.55M |
| NetPPE | 18.80M | 14.13M | 15.29M | 18.55M |
| AccumulatedDepreciation | -22.87M | -24.28M | -23.44M | -21.46M |
| GrossPPE | 41.67M | 38.41M | 38.73M | 40.01M |
| Leases | 4.48M | 4.38M | 4.33M | 3.37M |
| ConstructionInProgress | 9.02M | 1.58M | 531.00K | 1.83M |
| OtherProperties | 21.83M | 25.67M | 26.09M | 26.80M |
| MachineryFurnitureEquipment | 3.55M | 3.99M | 5.02M | 5.26M |
| BuildingsAndImprovements | 2.63M | 2.63M | 2.59M | 2.59M |
| LandAndImprovements | 164.00K | 164.00K | 164.00K | 164.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 102.41M | 68.75M | 118.16M | 156.63M |
| OtherCurrentAssets | 3.34M | 4.33M | 5.07M | 5.47M |
| AssetsHeldForSaleCurrent | 0.00 | 40.19M | ||
| RestrictedCash | 0.00 | 43.34M | 0.00 | |
| PrepaidAssets | 6.74M | |||
| Inventory | 287.00K | 326.00K | ||
| OtherInventories | 272.00K | 303.00K | ||
| FinishedGoods | 8.11M | |||
| WorkInProcess | 2.56M | |||
| RawMaterials | 15.00K | 23.00K | ||
| Receivables | 1.16M | 1.57M | 13.80M | 1.98M |
| OtherReceivables | 237.00K | 673.00K | 12.83M | 566.00K |
| DuefromRelatedPartiesCurrent | 19.00K | 73.00K | ||
| NotesReceivable | 0.00 | |||
| AccountsReceivable | 926.00K | 902.00K | 978.00K | 1.34M |
| AllowanceForDoubtfulAccountsReceivable | 0.00 | -184.00K | -184.00K | -184.00K |
| GrossAccountsReceivable | 926.00K | 1.09M | 1.16M | 1.52M |
| CashCashEquivalentsAndShortTermInvestments | 97.91M | 62.85M | 55.95M | 108.66M |
| OtherShortTermInvestments | 68.39M | 55.28M | 51.09M | 72.24M |
| CashAndCashEquivalents | 29.52M | 7.58M | 4.86M | 36.42M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -76.76M | -68.47M | -69.97M | -63.02M |
| RepaymentOfDebt | 0.00 | -43.22M | -155.29M | -466.00K |
| IssuanceOfDebt | 0.00 | 0.00 | ||
| IssuanceOfCapitalStock | 110.24M | 72.81M | 0.00 | 121.05M |
| CapitalExpenditure | -8.58M | -1.54M | -4.92M | -7.25M |
| InterestPaidSupplementalData | 7.00K | 1.17M | 8.54M | 7.16M |
| IncomeTaxPaidSupplementalData | 4.00K | 21.00K | 0.00 | 36.00K |
| EndCashPosition | 29.52M | 7.85M | 48.60M | 43.34M |
| BeginningCashPosition | 7.85M | 48.60M | 43.34M | 52.25M |
| EffectOfExchangeRateChanges | -27.00K | -320.00K | -827.00K | 217.00K |
| ChangesInCash | 21.70M | -40.43M | 6.08M | -9.12M |
| FinancingCashFlow | 110.58M | 29.59M | -155.29M | 121.19M |
| CashFlowFromContinuingFinancingActivities | 110.58M | 29.59M | -155.29M | 121.19M |
| NetOtherFinancingCharges | -588.00K | |||
| ProceedsFromStockOptionExercised | 346.00K | 0.00 | 1.00K | 608.00K |
| NetPreferredStockIssuance | 79.00M | 0.00 | 0.00 | |
| PreferredStockIssuance | 79.00M | 0.00 | 0.00 | |
| NetCommonStockIssuance | 31.24M | 72.81M | 0.00 | 121.05M |
| CommonStockIssuance | 31.24M | 72.81M | 0.00 | 121.05M |
| NetIssuancePaymentsOfDebt | 0.00 | -43.22M | -155.29M | -466.00K |
| NetShortTermDebtIssuance | 0.00 | 0.00 | ||
| ShortTermDebtPayments | 0.00 | 0.00 | ||
| ShortTermDebtIssuance | 0.00 | 0.00 | ||
| NetLongTermDebtIssuance | 0.00 | -43.22M | -155.29M | -466.00K |
| LongTermDebtPayments | 0.00 | -43.22M | -155.29M | -466.00K |
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -20.71M | -3.09M | 226.42M | -74.54M |
| CashFromDiscontinuedInvestingActivities | 0.00 | 0.00 | 162.31M | 0.00 |
| CashFlowFromContinuingInvestingActivities | -20.71M | -3.09M | 64.11M | -74.54M |
| NetOtherInvestingChanges | 60.00K | 98.00K | 594.00K | 6.76M |
| NetInvestmentPurchaseAndSale | -12.19M | -1.65M | 68.44M | -74.05M |
| SaleOfInvestment | 175.02M | 183.38M | 68.44M | 100.17M |
| PurchaseOfInvestment | -187.21M | -185.03M | 0.00 | -174.22M |
| NetBusinessPurchaseAndSale | 0.00 | |||
| SaleOfBusiness | 0.00 | |||
| PurchaseOfBusiness | 0.00 | |||
| NetPPEPurchaseAndSale | -8.58M | -1.54M | -4.92M | -7.25M |
| PurchaseOfPPE | -8.58M | -1.54M | -4.92M | -7.25M |
| OperatingCashFlow | -68.17M | -66.93M | -65.05M | -55.77M |
| CashFlowFromContinuingOperatingActivities | -68.17M | -66.93M | -65.05M | -55.77M |
| ChangeInWorkingCapital | 4.52M | 17.07M | -35.70M | -804.00K |
| ChangeInOtherWorkingCapital | 3.34M | 5.71M | -23.43M | 4.51M |
| ChangeInOtherCurrentLiabilities | -55.00K | -107.00K | -144.00K | 47.00K |
| ChangeInOtherCurrentAssets | 120.00K | 129.00K | -101.00K | 305.00K |
| ChangeInPayablesAndAccruedExpense | -278.00K | -1.64M | -1.14M | 2.28M |
| ChangeInAccruedExpense | -1.83M | 782.00K | -1.52M | 1.86M |
| ChangeInPayable | 1.55M | -2.42M | 379.00K | 420.00K |
| ChangeInAccountPayable | 1.55M | -2.42M | 379.00K | 420.00K |
| ChangeInPrepaidAssets | 981.00K | 748.00K | 2.63M | -1.38M |
| ChangeInInventory | 2.34M | -1.90M | ||
| ChangeInReceivables | 414.00K | 12.23M | -13.51M | -6.56M |
| ChangesInAccountReceivables | -24.00K | 76.00K | -2.17M | -6.23M |
| OtherNonCashItems | -1.02M | -13.07M | -79.98M | 6.50M |
| StockBasedCompensation | 9.47M | 9.89M | 10.21M | 13.90M |
| UnrealizedGainLossOnInvestmentSecurities | 0.00 | 0.00 | ||
| ProvisionandWriteOffofAssets | 0.00 | 0.00 | 944.00K | 1.27M |
| AssetImpairmentCharge | 40.32M | 10.84M | 1.12M | 543.00K |
| AmortizationOfSecurities | -883.00K | -1.81M | 832.00K | 1.23M |
| DeferredTax | -1.79M | -479.00K | -150.00K | -167.00K |
| DeferredIncomeTax | -1.79M | -479.00K | -150.00K | -167.00K |
| DepreciationAmortizationDepletion | 4.53M | 6.67M | 10.77M | 13.76M |
| DepreciationAndAmortization | 4.53M | 6.67M | 10.77M | 13.76M |
| AmortizationCashFlow | 3.06M | 4.85M | ||
| AmortizationOfIntangibles | 3.06M | 4.85M | ||
| Depreciation | 1.47M | 1.82M | ||
| OperatingGainsLosses | 2.91M | -132.00K | -1.40M | 153.00K |
| EarningsLossesFromEquityInvestments | 0.00 | 0.00 | -862.00K | 3.00K |
| NetForeignCurrencyExchangeGainLoss | 2.92M | 0.00 | 0.00 | 0.00 |
| NetIncomeFromContinuingOperations | -126.23M | -95.90M | 28.32M | -92.17M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for PGEN
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|